Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,490,281,597
+$115,793,499 QoQ
Shares Held
7,859,306
+12.8% QoQ
Ownership
0.507%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#28
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. AZN ranks #9 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,490,281,597 | 7,859,306 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,374,488,098 | 6,969,314 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||